Research suggests that mastic gum has a well-documented history of use for digestive health spanning over 2,500 years, and the modern scientific literature — including multiple reviews, systematic reviews, and several randomized controlled trials — generally supports its role in addressing a range of gastrointestinal conditions, including functional dyspepsia, inflammatory bowel disease, and H. pylori infection. Studies indicate that its bioactive compounds, primarily triterpenes and volatile constituents, appear to confer antioxidant and anti-inflammatory effects relevant to gut health, and a landmark 1998 study demonstrated direct antibacterial activity against H. pylori, a finding later supported by research identifying active components effective even against drug-resistant strains. Clinical trial evidence, while encouraging, remains relatively limited in scale; one RCT found significant symptom improvement in functional dyspepsia, others reported benefits in IBD patients including improved biomarkers and questionnaire scores, and a trial in a liver disease population yielded mixed results on primary endpoints while noting effects on gut microbiota diversity. The European Medicines Agency has formally recognized mastic gum as a traditional herbal medicine for mild digestive complaints, though researchers consistently note that the resin's chemical complexity makes it difficult to isolate which specific components drive particular effects, and that larger, more rigorous trials are needed before firmer conclusions can be drawn.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| A randomized, three-way crossover clinical trial on the efficacy of Mastiha b... | RCT | 2025 | Supports | 97 |
| The Effect of Mastic Chios Supplementation in Inflammatory Bowel Disease: A S... | Systematic review | 2023 | Supports | 95 |
| Chios Mastic Gum: Chemical Profile and Pharmacological Properties in Inflamma... | Review | 2023 | Supports | 95 |
| Effects of Pistacia genus on gastrointestinal tract disorders: A systematic a... | Systematic review | 2024 | Supports | 93 |
| Traditional uses, phytochemistry and pharmacology of Chios mastic gum (Pistac... | Review | 2020 | Supports | 93 |
| Overview of Chios Mastic Gum (Pistacia lentiscus) Effects on Human Health. | Review | 2022 | Supports | 92 |
| Regulation of faecal biomarkers in inflammatory bowel disease patients treate... | RCT | 2019 | Supports | 92 |
| Review: Chios mastic gum: a plant-produced resin exhibiting numerous diverse ... | Review | 2012 | Supports | 92 |
| Mastic gum kills Helicobacter pylori. | Other | 1998 | Supports | 90 |
| Plasma free amino acid profile in quiescent Inflammatory Bowel Disease patien... | RCT | 2019 | Supports | 88 |
| Herbal and plant therapy in patients with inflammatory bowel disease. | Review | 2015 | Supports | 88 |
| Chios Mastic Gum: A Promising Phytotherapeutic for Cardiometabolic Health. | Review | 2024 | Supports | 85 |
| Effects of Chios mastic gum on cardiometabolic risk factors. | Review | 2022 | Supports | 85 |
| Chemical Composition of the Essential Oil of Mastic Gum and their Antibacteri... | Other | 2014 | Supports | 85 |
| Persian Herbal Medicine in Functional Dyspepsia: A Systematic Review. | Systematic review | 2021 | Supports | 82 |
| Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Contr... | RCT | 2021 | Mixed | 82 |
| Mastiha has efficacy in immune-mediated inflammatory diseases through a micro... | RCT | 2021 | Supports | 80 |
| Mastiha (Pistacia lentiscus) Improves Gut Microbiota Diversity, Hepatic Steat... | Other | 2019 | Supports | 80 |
| A new approach against Helicobacter pylori using plants and its constituents:... | Review | 2022 | Supports | 78 |
| РАЗРАБОТКА РЕЦЕПТУРЫ И ТЕХНОЛОГИИ ПЕНООБРАЗОВАТЕЛЯ ИЗ МАСТИЧНОЙ (PISTACIA LEN... | Other | 2022 | Supports | 72 |
| A review of the efficacy of traditional Iranian medicine for inflammatory bow... | Review | 2010 | Supports | 72 |
| Traditional Persian topical medications for gastrointestinal diseases. | Review | 2017 | Supports | 70 |
| Helicobacter pylori neutrophil activating protein as target for new drugs aga... | Other | 2011 | Supports | 65 |